Loading…
Based on limited metadata, this warning letter was issued to Human Biologics of Texas/Globus Medical on October 30, 2018, regarding products classified as "Other" by the FDA. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The issuing office is also not specified in the metadata provided, limiting visibility into which FDA division or center initiated this enforcement action.